HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MV-ONE

neutraceutical consisting of cholecalciferol (1500 IU), gamma-tocopherol (300 mg), and alpha-lipoic acid (600 mg)

Networked: 11 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Duprex, W Paul: 1 article (04/2013)
2.	Lemon, Ken: 1 article (04/2013)
3.	Ludlow, Martin: 1 article (04/2013)
4.	McQuaid, Stephen: 1 article (04/2013)
5.	Millar, Emma L: 1 article (04/2013)
6.	Osterhaus, Albert D M E: 1 article (04/2013)
7.	Verburgh, R Joyce: 1 article (04/2013)
8.	Yüksel, Selma: 1 article (04/2013)
9.	de Swart, Rik L: 1 article (04/2013)
10.	de Vries, Rory D: 1 article (04/2013)

Related Diseases

1.	Malnutrition (Nutritional Deficiencies) 11/01/2009 - "In the present study was analyzed the benefits of combined nutritional support in patients with COPD under MV. One hundred ninety two (192) patients with COPD were admitted to our Intensive Care Unit (ICU), due to severe respiratory failure of whom 163 (84.9%) patients were under MV. In 18 (11.04%) patients after the 10th day under MV and due to severe malnutrition (serum albumin < 2.5 gm/dl, total lymphocyte count (TLC) < 900/mm3), added in the enteral nutrition (EN) of 1800 Kcals and parenteral nutrition (PN) of 2000 Kcals, at high concentration in lipids from central venous catheter. "
2.	Chronic Obstructive Pulmonary Disease (COPD) 11/01/2009 - "In the present study was analyzed the benefits of combined nutritional support in patients with COPD under MV. One hundred ninety two (192) patients with COPD were admitted to our Intensive Care Unit (ICU), due to severe respiratory failure of whom 163 (84.9%) patients were under MV. In 18 (11.04%) patients after the 10th day under MV and due to severe malnutrition (serum albumin < 2.5 gm/dl, total lymphocyte count (TLC) < 900/mm3), added in the enteral nutrition (EN) of 1800 Kcals and parenteral nutrition (PN) of 2000 Kcals, at high concentration in lipids from central venous catheter. "
3.	Respiratory Insufficiency (Respiratory Failure) 11/01/2009 - "In the present study was analyzed the benefits of combined nutritional support in patients with COPD under MV. One hundred ninety two (192) patients with COPD were admitted to our Intensive Care Unit (ICU), due to severe respiratory failure of whom 163 (84.9%) patients were under MV. In 18 (11.04%) patients after the 10th day under MV and due to severe malnutrition (serum albumin < 2.5 gm/dl, total lymphocyte count (TLC) < 900/mm3), added in the enteral nutrition (EN) of 1800 Kcals and parenteral nutrition (PN) of 2000 Kcals, at high concentration in lipids from central venous catheter. "
4.	Infections 04/01/2013 - "Measles virus (MV), one of the most contagious viruses infecting humans, causes a systemic infection leading to fever, immune suppression, and a characteristic maculopapular rash. " 06/23/1997 - "By testing a series of overlapping peptides corresponding to the 126 amino acid SCR1-2 region for inhibition of MV infection, two domains were identified that interacted with MV. One domain was found within SCR1 (amino acids 37-56) and another within SCR2 (amino acids 85-104). "
5.	Carcinoma (Carcinomatosis) 01/01/2004 - "Two groups of 10 consecutive patients each were treated from January 2003 through April 2003 with neoadjuvant (45 Gy) or adjuvant (54 Gy) radio(chemo)therapy in single fractions of 5 days a week 1.8 Gy for rectal carcinoma, using a photon energy of 15 MV. One group was positioned in a prone position without an immobilization device, the other group was positioned on our bellyboard. " 01/01/2013 - "Our data suggest that MV, one of the widely used vaccines in China, has the ability to inhibit the growth of mouse lung carcinoma and may prove useful in the further exploration of the application of this approach in the treatment of human advanced lung cancer."

Related Drugs and Biologics

1.	Serum Albumin
2.	Lipids
3.	Vaccines
4.	Quinidine (Chinidin)
5.	Peptides (Polypeptides)
6.	Amino Acids

Related Therapies and Procedures

1.	Central Venous Catheters
2.	Nutritional Support (Artificial Feeding)
3.	Parenteral Nutrition
4.	Enteral Nutrition (Feeding, Tube)
5.	Cardiac Resynchronization Therapy